Keyphrases
Apoptosis
25%
Cell Cycle Pathway
100%
Clinical Outcomes
100%
Clinical Tissues
12%
Deregulation
12%
Disease-free Survival
12%
Downstream Genes
12%
Gene Expression
12%
Growth Control
12%
HBV-related Hepatocellular Carcinoma
12%
Hepatocellular Carcinoma
100%
Intracellular Expression
25%
Large Tumors
12%
Molecular Mechanism
12%
Oncogenesis
12%
Overall Survival
12%
Overexpression
12%
P21Cip1
100%
P53 Expression
50%
Proliferating Cell nuclear Antigen
12%
Terminal Deoxynucleotidyl Transferase dUTP Nick End Labeling
12%
Tissue Specimens
12%
Tumor Progression
12%
Tumor Size
12%
Medicine and Dentistry
Carcinogenesis
9%
Cell Cycle
100%
Deoxyuridine
9%
Disease Free Survival
9%
DNA Nucleotidylexotransferase
9%
Gene Expression
9%
Growth Regulation
9%
Hepatitis B Virus
9%
Hepatocellular Carcinoma
100%
Neoplasm
9%
Overall Survival
9%
P21
100%
Programmed Cell Death
18%
Proliferating Cell Nuclear Antigen
9%
Protein P53
100%
Tumor Progression
9%
TUNEL Assay
9%
Biochemistry, Genetics and Molecular Biology
Carcinogenesis
9%
Cell Cycle
100%
Deoxyuridine
9%
Disease Free Survival
9%
Gene Expression
9%
Growth Regulation
9%
Hepatitis B Virus
9%
Overall Survival
9%
P21
100%
P53
100%
Programmed Cell Death
18%
Proliferating Cell Nuclear Antigen
9%
Terminal Deoxynucleotidyl Transferase
9%
Tumor Progression
9%
Tumor Volume
9%
TUNEL Assay
9%
Pharmacology, Toxicology and Pharmaceutical Science
Carcinogenesis
9%
Cycline
9%
Deoxyuridine
9%
Disease Free Survival
9%
DNA Nucleotidylexotransferase
9%
Hepatitis B Virus
9%
Liver Cell Carcinoma
100%
Neoplasm
9%
Overall Survival
9%
Protein P53
100%
Tumor Growth
9%
Immunology and Microbiology
Cell Cycle
100%
Cycline
9%
Disease Free Survival
9%
Gene Expression
9%
Growth Regulation
9%
Hepatitis B Virus
9%
Overall Survival
9%
P53
100%
Programmed Cell Death
18%
Tumor Volume
9%